Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease

Protease-activated receptors (PARs) are coagulation protease targets, and they increase expression of inflammatory cytokines and chemokines in various diseases. Of all PARs, previous reports have shown that PAR1 or PAR2 inhibition is protective against diabetic glomerular injury. However, how PAR1 a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Am J Physiol Renal Physiol
Main Authors: Mitsui, Shohei, Oe, Yuji, Sekimoto, Akiyo, Sato, Emiko, Hashizume, Yamato, Yamakage, Shu, Kumakura, Satoshi, Sato, Hiroshi, Ito, Sadayoshi, Takahashi, Nobuyuki
פורמט: Artigo
שפה:Inglês
יצא לאור: American Physiological Society 2020
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7294339/
https://ncbi.nlm.nih.gov/pubmed/32200667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00595.2019
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים